| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/30/2005 | EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 03/30/2005 | EP0929232B1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 03/30/2005 | EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof |
| 03/30/2005 | CN1602427A Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 03/30/2005 | CN1602355A Human fibroblast growth factor-related compositions |
| 03/30/2005 | CN1602317A Angiopoietin-2 specific binding agents |
| 03/30/2005 | CN1602207A Methods for inhibiting ocular processes |
| 03/30/2005 | CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/30/2005 | CN1600147A Immunity strengthened feedstuff additive of glycopeptide composite, preparation method and usage |
| 03/30/2005 | CN1194990C Polypeptide motif bound with human CD95 and its polypeptide |
| 03/30/2005 | CN1194989C Novel human protein able to suppress cancer cell growth and its coding sequence |
| 03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/29/2005 | US6872811 HRPCa9 and HRPCa10 nucleic acids and polypeptides |
| 03/29/2005 | US6872750 Modulating angiogenesis |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/29/2005 | US6872567 Propagating and recovering preferential cells from culture; obtain cell sample, expose to antibody, separate cells bound to antibody, recover and propagate bound cells |
| 03/29/2005 | US6872559 Diagnosis of urogenital disorders |
| 03/29/2005 | US6872558 Heparanase-2 a member of the heparanase protein family |
| 03/29/2005 | US6872554 For therapy of Alzheimer's disease; immunization |
| 03/29/2005 | US6872520 Peptide for use in the detection of viral infection and diseases |
| 03/29/2005 | US6872393 Polyalkylene oxide-modified single chain polypeptides |
| 03/29/2005 | US6872392 Humanized antibodies |
| 03/29/2005 | CA2323506C Mammalian blood loss-induced gene, kd312 |
| 03/29/2005 | CA2065346C Tumor necrosis factor-.alpha. and-.beta. receptors |
| 03/29/2005 | CA1341477C Method of reducing immunoglobulin e responses |
| 03/24/2005 | WO2005026733A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | WO2005026731A1 Combination of anti-hpv-16 and 18 antibodies and uses thereof |
| 03/24/2005 | WO2005026375A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/24/2005 | WO2005026336A1 Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same |
| 03/24/2005 | WO2005026326A2 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 03/24/2005 | WO2005026325A2 Bivalent targeting of cell surfaces |
| 03/24/2005 | WO2005026321A2 Protein o-sulfonation |
| 03/24/2005 | WO2005026317A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 03/24/2005 | WO2005026314A2 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 03/24/2005 | WO2005026211A2 Anti-ghrelin antibodies |
| 03/24/2005 | WO2005026210A2 Therapeutic binding molecules |
| 03/24/2005 | WO2005026209A2 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | WO2005026205A2 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | WO2005026203A2 Dna promoters and anthrax vaccines |
| 03/24/2005 | WO2005025650A1 Apheresis device |
| 03/24/2005 | WO2005025618A2 Treatment of rheumatoid arthritis with cd99 antagonists |
| 03/24/2005 | WO2005025617A2 Methods and compositions for treating herpes infections |
| 03/24/2005 | WO2005025616A1 Use of antibody |
| 03/24/2005 | WO2005025615A2 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 03/24/2005 | WO2005025612A1 Vaccines |
| 03/24/2005 | WO2005025610A1 Use of markk or markk antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of mark or tau protein |
| 03/24/2005 | WO2005025603A2 Methods of using wisp antagonists |
| 03/24/2005 | WO2005025516A2 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | WO2005025509A2 Methods and materials for treating autoimmune diseases and conditions |
| 03/24/2005 | WO2005012493A3 Anti-cd19 antibodies |
| 03/24/2005 | WO2005005604A3 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 03/24/2005 | WO2005003345A3 Look-through mutagenesis |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004106379A8 Immunotherapy of rectal cancer |
| 03/24/2005 | WO2004094673A3 Methods for monitoring drug activities in vivo |
| 03/24/2005 | WO2004084836A3 Methods for treating taxol-induced gut disorder |
| 03/24/2005 | WO2004076644A3 A composition for delivering an agent to a target cell and uses thereof |
| 03/24/2005 | WO2004073319A8 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 03/24/2005 | WO2004072262A3 Cultured cd14+ antigen presenting cells |
| 03/24/2005 | WO2004069860A3 Isg15-conjugated proteins |
| 03/24/2005 | WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004066956A3 Uses of integrin alphavbeta3 antagonists |
| 03/24/2005 | WO2004065569A3 Multi-functional antibodies |
| 03/24/2005 | WO2004065540A3 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 03/24/2005 | WO2004065409A3 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines |
| 03/24/2005 | WO2004059285A3 Tumor killing/tumor regression using cxcr4 antagonists |
| 03/24/2005 | WO2004052933A3 Peptide oligomers for use as hiv vaccines |
| 03/24/2005 | WO2004047761A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 03/24/2005 | WO2004014955A9 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003016501A3 Recombinant antibodies, and compositions and methods for making and using the same |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 03/24/2005 | US20050065326 Immunoglobulin specific to orphan nuclear receptor (TR2) for use as tool in prevention and treatment of cell proliferative disorders |
| 03/24/2005 | US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065136 Administering by mouth, transdermal; controlling concentration |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065083 Promoting survival of nerve cells; stimulating cell differentiation; amyotropic lateral scleerosis |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064541 For immunoregulation and/or treatment of inflammation; muteins, |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064518 Monoclonal antibody for use in prevention and treatment of ovarian cancer; immunotherapeutics |
| 03/24/2005 | US20050064517 Atazanavir conjugates and antibodies useful in immunoassay |
| 03/24/2005 | US20050064514 Immunoglobulins for use as tool in treatment and prevention of cell proliferative disorders through enhancement of antibody-dependent cell mediated cytotoxicity (ADCC) or complement dependent cytotoxicity (CDC); immunotherapy |
| 03/24/2005 | US20050064512 Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 03/24/2005 | US20050064499 Expression vector coding nucleotide sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064492 Compositions and methods for the diagnosis and treatment of tumor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |